Hamilton Beach Brands Holding Co. - 10-Q Summary (Q3 2024)
Business Context and Reporting Period
This report covers the quarterly period ended September 30, 2024. Hamilton Beach Brands Holding Company (HBB) is a leading designer, marketer, and distributor of branded small electric household and specialty housewares appliances, as well as commercial products and healthcare management software. The company operates as a single reportable segment. Results are seasonal, with a majority of revenue and operating profit typically occurring in the second half of the year.
Key Financial Metrics
| Metric | Q3 2024 | Q3 2023 | YTD 2024 | YTD 2023 |
|---|---|---|---|---|
| Revenue | $156.7 million | $153.6 million | $441.2 million | $419.0 million |
| Gross Profit | $43.9 million | $40.1 million | $114.5 million | $88.4 million |
| Gross Margin | 28.0% | 26.1% | 25.9% | 21.1% |
| Operating Profit | $10.6 million | $14.4 million | $19.6 million | $10.1 million |
| Net Income | $1.9 million | $10.3 million | $6.8 million | $5.7 million |
| Diluted EPS | $0.14 | $0.74 | $0.48 | $0.40 |
| Cash & Equivalents | $22.6 million | $1.6 million | As of Sept 30, 2024 | |
| Revolving Credit Outstanding | $50.0 million | $0 | As of Sept 30, 2024 | |
| Operating Cash Flow (YTD) | $35.2 million | $68.7 million (YTD 2023) |
Material Changes vs. Prior Period
- Revenue Growth: Q3 revenue increased 2.0% year-over-year, driven by favorable product mix and increased unit volume in US and Mexican markets, partially offset by price decreases and foreign currency impacts. The acquisition of HealthBeacon contributed $1.2 million in Q3 revenue.
- Margin Expansion: Gross margin improved to 28.0% in Q3 (from 26.1% in 2023) due to lower product costs and favorable mix.
- SG&A Increase: Selling, general, and administrative expenses rose 29.9% in Q3. This was primarily due to $2.9 million in increased non-cash equity compensation, $1.8 million in HealthBeacon expenses, and the absence of a $0.9 million insurance recovery in the prior year.
- Pension Termination Charge: A one-time, non-cash pension termination expense of $7.6 million was recorded in Q3 2024 related to the settlement of the U.S. defined benefit pension plan. This significantly reduced Q3 net income compared to the prior year.
- Acquisition: The company acquired HealthBeacon PLC in February 2024 for approximately $7.5 million. HealthBeacon contributed $2.6 million in revenue and $3.7 million in operating loss for the nine months ended September 30, 2024.
Guidance, Outlook, and Risks
Liquidity and Debt: The company maintains a $150 million senior secured revolving credit facility (HBB Facility) expiring June 30, 2025. As of September 30, 2024, $50 million was outstanding, with $98.5 million in excess availability. The facility has been classified as a current liability pending refinancing, which management believes is probable.
Capital Allocation: The company repurchased $5.3 million of its Class A Common Stock in Q3 2024. As of September 30, 2024, $15.7 million remained authorized under the current repurchase program.
Risks and Contingencies:
- Seasonality: Results are highly seasonal; Q3 results are not necessarily indicative of full-year performance.
- Refinancing: The HBB Facility expires in June 2025; failure to refinance could impact liquidity classification.
- Legal/Environmental: The company faces various legal proceedings and environmental remediation obligations. Accrued environmental obligations were $3.5 million as of September 30, 2024, with a possible additional range of $0 to $1.7 million.
- Integration: The company is integrating HealthBeacon, which is not yet included in the assessment of internal controls over financial reporting.
Investor Verification Checklist
- Verify the status and terms of the refinancing for the $150 million HBB Facility expiring June 30, 2025.
- Confirm the final purchase price allocation for the HealthBeacon acquisition and its impact on future goodwill amortization.
- Monitor the completion of the U.S. pension plan termination and the transfer of surplus assets to a qualified replacement plan.
- Review the trajectory of SG&A expenses, specifically the sustainability of equity compensation costs relative to stock price performance.
- Assess the impact of foreign currency fluctuations on future revenue and margins, given the company's international exposure.